Business
Why the Starpharma (ASX:SPL) share price hit a record high today
The Starpharma Holdings Limited (ASX: SPL) share price has been a very positive performer on Tuesday.
At one stage today, the dendrimer product developer’s shares jumped 7.5% to hit a record high of $2.10.
The Starpharma share price has since given back some of these gains but is still up 4% to $2.03 at the time of writing.
Why is the Starpharma share price racing higher?
Investors have been buying Starpharma’s shares after it provided an update on its AZD0466 product.
AZD0466 is a highly optimised nanomedicine formulation of AstraZeneca’s novel dual Bcl2/xL inhibitor which utilises Starpharma’s DEP technology. It utilises DEP to improve the formulation characteristics and therapeutic index of the anti-cancer agent and is…
-
Noosa News22 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General20 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Business22 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News22 hours agoGrow it local | Noosa Today